General Information


DRACP ID  DRACP04245

Peptide Name  

Sequence  IIRWWWRII

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C69H100N18O10

Absent amino acids  ACDEFGHKLMNPQSTVY

Common amino acids  I

Mass  148455

Pl  12.5

Basic residues  2

Acidic residues  0

Hydrophobic residues  7

Net charge  2

Boman Index  -317

Hydrophobicity  70

Aliphatic Index  173.33

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  16500

Absorbance 280nm  2062.5

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34964342

Title  Novel Arginine End-Tagging Antimicrobial Peptides to Combat Multidrug-Resistant Bacteria

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18646

DRACP is developed by Dr.Zheng's team.